ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,169,060 | +67789.7% | 43,508 | -6.8% | 0.01% | -53.8% |
| Q4 2022 | $1,722 | -99.9% | 46,658 | -1.8% | 0.01% | 0.0% |
| Q3 2022 | $1,488,000 | -27.7% | 47,503 | -1.6% | 0.01% | -23.5% |
| Q2 2022 | $2,059,000 | -6.9% | 48,258 | -0.2% | 0.02% | +6.2% |
| Q1 2022 | $2,211,000 | -5.8% | 48,333 | +5.0% | 0.02% | -5.9% |
| Q4 2021 | $2,348,000 | -24.8% | 46,052 | -2.6% | 0.02% | -10.5% |
| Q3 2021 | $3,122,000 | -5.8% | 47,282 | -16.7% | 0.02% | -5.0% |
| Q2 2021 | $3,314,000 | -19.7% | 56,757 | -1.5% | 0.02% | -20.0% |
| Q1 2021 | $4,126,000 | -16.4% | 57,640 | -4.1% | 0.02% | -19.4% |
| Q4 2020 | $4,935,000 | +36.3% | 60,131 | -2.2% | 0.03% | +19.2% |
| Q3 2020 | $3,622,000 | +20.3% | 61,513 | -0.7% | 0.03% | +13.0% |
| Q2 2020 | $3,011,000 | +34.8% | 61,973 | +7.9% | 0.02% | +15.0% |
| Q1 2020 | $2,233,000 | -6.3% | 57,424 | +0.0% | 0.02% | +11.1% |
| Q4 2019 | $2,384,000 | -27.6% | 57,412 | -35.7% | 0.02% | -30.8% |
| Q3 2019 | $3,291,000 | +30.2% | 89,234 | +0.7% | 0.03% | +30.0% |
| Q2 2019 | $2,527,000 | – | 88,607 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
| Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
| M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
| WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
| Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
| Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
| JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
| COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
| Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
| Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |